Epocrates Q1 FY12: net loss $1.4M; diluted EPS −$0.06

Key figures from this report

These are the numbers Epocrates reported for Q1 FY12, the quarter ended Mar 31, 2012, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

1. Net income−$1.4MNo year-earlier figure tagged10-Q income statement, on EDGAR
2. Diluted EPS−$0.06No year-earlier figure tagged10-Q income statement, on EDGAR
3. Cash and cash equivalents$72.8MNo year-earlier figure taggedCash and equivalents only; the company page adds short-term investments.10-Q balance sheet, on EDGAR
4. Cash from operations−$2.8MNo year-earlier figure tagged10-Q cash flow statement, on EDGAR